Inside Cover: Novel Triazolopyrimidine-Derived Cannabinoid Receptor 2 Agonists as Potential Treatment for Inflammatory Kidney Diseases (ChemMedChem 2/2016) - Nettekoven, Matthias; Adam, Jean-Michel; Bendels, Stefanie; Bissantz, Catarina; Fingerle, Jürgen; Grether, Uwe; Grüner, Sabine; Guba, Wolfgang; Kimbara, Atsushi; Ottaviani, Giorgio; Püllmann, Bernd; Rogers-Evans, Mark; et al. (ChemMedChem, 2016)
Keywords: CB2 receptor agonists; fibrosis; inflammation; lead optimization; triazolopyrimidines